Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Ardelyx, Inc. - Common Stock (NQ:ARDX)

5.960 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ardelyx, Inc. - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
18 19 Next >
Why Is Ardelyx (ARDX) Stock Up 38% Today?
Ardelyx (ARDX) stock is taking off on Thursday after an advisory committee to the FDA voted in favor of its kidney disease drug. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
Upgrades 
Via Benzinga
FDA Signals Unclear Clinical Benefits Of Ardelyx's Kidney Disease Candidate
 
Via Benzinga
FDA Plans To Convene AdComm For Ardelyx's Tenapanor For CKD Patients On Dialysis
 
Via Benzinga
Ukraine Asserts It Does Not Take Blame For Poland Missile Attack, Crypto Exchange Gemini Suffers $485M In Outflows, FTX, Bahamas Regulator Lock Horns Over Control Of Bankruptcy Proceedings: Top Stories Thursday, Nov. 17
CNBC 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Why NetEase Shares Are Trading Lower; Here Are 25 Stocks Moving Premarket
Gainers 
Via Benzinga
Despite Concerns, FDA Advisory Committee Votes In Favor Of Ardelyx's Kidney Disease Candidate
 
Via Benzinga
Cisco, Bath & Body Works And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target. 
Via Benzinga
US Stocks Mostly Lower; Nasdaq Drops Over 100 Points
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping more than 100 points on Monday. 
Via Benzinga
Preview: Ardelyx's Earnings
Ardelyx (NASDAQ:ARDX) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Ardelyx will report... 
Via Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
October proved to be a mixed month for the Food and Drug Administration’s regulatory decisions. Two new molecular entities, or NMEs, were approved during the month, bringing the tally for the... 
Via Benzinga
10 Best Medical Stocks Under $5
The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the... 
Via Talk Markets
Why Cango Shares Are Trading Higher; Here Are 27 Stocks Moving Premarket
Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) rose 43.2% to $0.2097 in pre-market trading after jumping over 16% on Tuesday. Adamis Pharmaceuticals recently announced a review of strategic... 
Via Benzinga
Ardelyx, Inc. (NASDAQ:ARDX) Investor Alert: Investigation over Possible Breaches of Fiduciary Duties
San Diego, CA -- (SBWIRE) -- 09/06/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Ardelyx, Inc. 
Via SBWire
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers 
Via Benzinga
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
Ionis (NASDAQ: IONS) announced that Eplontersen met co-primary and secondary endpoints in interim analysis of the Phase 3 NEURO-TTRansform study for hereditary transthyretin-mediated amyloid... 
Via Benzinga
Ardelyx, Inc. (NASDAQ:ARDX) Long Term Investor Alert: Lawsuit Filed Against Directors
San Diego, CA -- (SBWIRE) -- 06/03/2022 -- An investorsin shares of Ardelyx, Inc. (NASDAQ:ARDX) filed a lawsuit against certain directors of Ardelyx, Inc over alleged breaches of fiduciary duties. 
Via SBWire
21 Stocks Moving in Wednesday's Pre-Market Session
Gainers The Singing Machine Company, Inc. (NASDAQ: MICS) shares rose 47.3% to $4.05 in pre-market trading. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022
Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two... 
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Rises 70 Points; Eliem Therapeutics Shares Slide
U.S. stocks pared losses toward the end of trading, with the Nasdaq Composite gaining around 70 points on Monday. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Mid-Day Market Update: Crude Oil Tumbles Over 6%; Nkarta Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 400 points on Monday. 
Via Benzinga
34 Stocks Moving In Monday's Mid-Day Session
Gainers Nkarta, Inc. (NASDAQ: NKTX) shares jumped 108.6% to $16.21 after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen... 
Via Benzinga
Why Ardelyx Shares Are Rising
Ardelyx Inc (NASDAQ: ARDX) shares are trading higher by 29.32% at $0.97 after the company reported it received an interim response from the OND, CDER and FDA for the company’s second level of appeal of... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
26 Stocks Moving in Monday's Pre-Market Session
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares rose 88.4% to $2.30 in pre-market trading. Erytech Pharma recently announced publication of results from Eryapasse Phase 2 trial... 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.